Pacira BioSciences, Inc. PCRX Payments to Acquire Short-Term Investments
Payments to Acquire Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s payments to acquire short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s payments to acquire short-term investments?
- Pacira BioSciences, Inc. (PCRX) reported payments to acquire short-term investments of $0 in Q1 2026.
- How has Pacira BioSciences, Inc.'s payments to acquire short-term investments changed year-over-year?
- Pacira BioSciences, Inc.'s payments to acquire short-term investments decreased by 100.0% year-over-year, from $69.63M to $0.
- What is the long-term trend for Pacira BioSciences, Inc.'s payments to acquire short-term investments?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s payments to acquire short-term investments has grown at a -30.7% compound annual growth rate (CAGR), from $611.49M to $141.04M.